Navigation Links
Dyadic International Announces Date and Time of Third Quarter 2011 Financial Results Release and Conference Call

JUPITER, Fla., Oct. 20, 2011 /PRNewswire/ -- Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company, today announced that it will report its financial results for the third quarter ended September 30, 2011 and will host a conference call to discuss those financial results as follows:


Financial Results Release:  After market close, Thursday, November 3, 2011.

Conference Call:  5:00 p.m. Eastern Time, Thursday, November 3, 2011.

In order to participate in the live conference call, please use the following dial-in numbers five to ten minutes prior to start time:

Calling from the United States or Canada:  888-661-5176.

Calling from other countries:  913-312-0702.

Please reference Passcode:  3489907.

A replay of the conference call will be available on the Dyadic website ( shortly after the live event.

About Dyadic

Dyadic is a global biotechnology company that uses its patented and proprietary technologies for the discovery, development, manufacture and sale of enzyme and protein products for the bioenergy, biopharmaceutical and industrial enzyme industries.

Cautionary Statement for Forward-Looking Statements

Certain statements contained in this press release are forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause Dyadic's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Except as required by law, Dyadic expressly disclaims any intent or obligation to update any forward-looking statements.

SOURCE Dyadic International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Dyadic International Raises $3 Million in Private Placement of Convertible Notes
2. Dyadic International Reports 2011 Second Quarter Financial Results
3. Dyadic International Announces Date of Second Quarter 2011 Financial Results Release and Conference Call
4. Dyadic International Enters Into Research and License Agreement With Major Player in the Animal Feed Industry
5. Dyadic to Present at the World Congress on Industrial Biotechnology & Bioprocessing
6. Dyadic Netherlands Enters Into R&D Collaboration With Sanofi Pasteur and EnGen Bio
7. New U.S. Patent Issued to Dyadic International
8. Dyadic International to Present at Advanced Biofuels Leadership Conference
9. Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets
10. Dyadic International Reports 2010 Fiscal Year Financial Results
11. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):